SLC41A1 and Alzheimer disease: Conversely, SLC41A1 levels were significantly increased in both APP/PS1 mice (Fig. 3a) and human AD samples, together with PM20D1 (Fig. 3b), which raises the question whether SLC41A1 might have similar neuroprotective functions as PM20D1 or, alternatively, whether it participates of AD pathology.